| 000 | 00922nam a2200241Ia 4500 | ||
|---|---|---|---|
| 001 | u1599 | ||
| 008 | 220414s2005 ||||||||||||||||| ||eng u | ||
| 020 | _a9780857112767 | ||
| 040 | _cOMC | ||
| 041 | _aeng | ||
| 050 | _aQV 740 FA 1 B661 2017 | ||
| 060 | _aQV 740 FA 1 B661 2017 | ||
| 082 | _aQV 740 FA 1 B661 2017 | ||
| 100 | _aRoyal Pharmaceutical Society of Great Britain | ||
| 245 | 0 | _aBNF 73 | |
| 260 |
_aLondon _bBMJ Pub., _c2005 |
||
| 300 | _a1458 p. | ||
| 365 | _cOMR | ||
| 500 | _aQV 740 FA 1 B661 2017 NLM 1 20013927 STACKS OMC-SOHAR OR23.10 Y Y BOOK 4/5/2017 QV 740 FA 1 B661 2017 NLM 2 20013946 5/11/2019 31/10/2019 STACKS OMC-SOHAR 3 OR23.10 Y Y BOOK 8/5/2017 QV 740 FA 1 B661 2017 NLM 3 20013947 3/12/2020 3/12/2020 1 STACKS OMC-SOHAR OR23.10 N Y BOOK 8/5/2017 Reference | ||
| 650 | _aFormularies as Topic United Kingdom | ||
| 700 | _aRoyal Pharmaceutical Society of Great Britain | ||
| 942 | _cLBK | ||
| 999 |
_c4755 _d4755 |
||